IP Library Granted Patent US 8,790,606
Granted Patent B2
US 8,790,606 · App. 13/978,725 · Granted Jul 29, 2014

Process and apparatus for treating a gas stream

View Patent ↗
Loading inventors, assignments & file history…
Monitor This Case
Get email alerts when status or documents change.
Order Certified Copies
Most orders are placed with the USPTO same day — all within 24 business hours.
Order via The Patent Place →
Pre-filled with this patent's details
Quick Facts
Patent No.
US 8,790,606
App. No.
13/978,725
Granted
Jul 29, 2014
Kind
B2
Abstract

A process of treating hydrogen gas liberated from the acid or alkaline dissolution of a metal is provided. The process comprises a step of passing the liberated hydrogen gas through a reactor containing an oxidizing agent for oxidation of the hydrogen gas into water, followed by a step of regenerating the oxidizing agent. Also provided is an apparatus for carrying out the process, the apparatus comprising a reactor containing the oxidizing agent, wherein the reactor is at least partially immersed in an alumina bath.

Claims (19)

1. A process of treating hydrogen gas liberated from the acid or alkaline dissolution of a metal, the process comprising a step of passing the liberated hydrogen gas through a reactor containing an oxidising agent for oxidation of the hydrogen gas into water, followed by a step of regenerating the oxidising agent, wherein the oxidising agent is diluted with an inert diluent.

2. A process according to claim 1 , wherein a step of regenerating the oxidising agent is carried out after each oxidation step.

3. A process according to claim 1 , wherein the oxidising agent comprises a metal oxide in bulk form or finely dispersed on the surface of an inert support.

4. A process according to claim 1 , wherein the inert diluent comprises stainless steel pellets.

5. A process according to claim 1 , wherein the oxidising agent comprises copper oxide.

6. A process according to claim 1 , wherein the step of regenerating the oxidising agent comprises passing a gas containing oxygen through the reactor containing the oxidising agent to be regenerated.

7. A process according to claim 1 , wherein the metal, the dissolution of which liberates hydrogen gas, comprises uranium.

8. A process according to claim 7 , wherein the metal is a uranium-aluminium alloy.

9. A process according to claim 1 , wherein the reactor is at least partially immersed in an alumina bath.

10. A process according to claim 1 , wherein the alumina bath is supplied with one or more heating elements.

11. An apparatus for carrying out a process according to claim 1 , the apparatus comprising a reactor containing an oxidising agent for the oxidation of hydrogen gas into water, wherein the reactor is at least partially immersed in an alumina bath.

12. An apparatus according to claim 11 , wherein the alumina bath is supplied with one or more external heating elements.

13. An apparatus according to claim 11 , wherein the oxidising agent comprises a metal oxide in bulk form or a metal oxide finely dispersed on the surface of an inert support.

14. An apparatus according to claim 11 , wherein the oxidising agent is diluted with an inert diluent.

15. An apparatus according to claim 14 , wherein the inert diluent comprises stainless steel pellets.

16. An apparatus according to claim 11 , wherein the oxidising agent comprises copper oxide.

17. A process of treating hydrogen gas liberated from the acid or alkaline dissolution of a metal, the process comprising a step of passing the liberated hydrogen gas through a reactor containing an oxidising agent for oxidation of the hydrogen gas into water, wherein the oxidising agent comprises a metal oxide finely dispersed on an inert carrier and/or diluted with an inert diluent.

18. A process according to claim 17 , further comprising a step of regenerating the oxidising agent.

19. A process according to claim 17 , wherein the metal oxide comprises copper oxide.

Assignments (6)
RELEASE OF PATENT SECURITY INTERESTS RECORDED AT REEL 032480, FRAME 0001 Recorded Nov 16, 2023
From: DEUTSCHE BANK AG NEW YORK BRANCH, AS COLLATERAL AGENT
To: THERAKOS, INC.; MALLINCKRODT INTERNATIONAL FINANCE S.A.; MALLINCKRODT CB LLC; MALLINCKRODT FINANCE GMBH; MALLINCKRODT US HOLDINGS LLC (F/K/A MALLINCKRODT US HOLDINGS INC.); MALLINCKRODT CARRIBEAN, INC.; MALLINCKRODT US POOL LLC; MNK 2011 LLC (F/K/A MALLINCKRODT INC.); LUDLOW LLC (F/K/A LUDLOW CORPORATION); CNS THERAPEUTICS, INC.; MALLINCKRODT ENTERPRISES HOLDINGS LLC (F/K/A MALLINCKRODT ENTERPRISES HOLDINGS, INC.); MALLINCKRODT ENTERPRISES LLC; MALLINCKRODT LLC; LAFAYETTE PHARMACEUTICALS LLC; LIEBEL-FLARSHEIM COMPANY LLC; MALLINCKRODT BRAND PHARMACEUTICALS LLC (F/K/A MALLINCKRODT BRAND PHARMACEUTICALS, INC.); MALLINCKRODT VETERINARY, INC.; MALLINCKRODT US HOLDINGS LLC; IMC EXPLORATION COMPANY; MEH, INC.; MALLINCKRODT HOSPITAL PRODUCTS IP UNLIMITED COMPANY (F/K/A MALLINCKRODT HOSPITAL PRODUCTS IP LIMITED); MALLINCKRODT ARD IP UNLIMITED COMPANY (F/K/A MALLINCKRODT ARD IP LIMITED); OCERA THERAPEUTICS LLC (F/K/A OCERA THERAPEUTICS, INC.); SPECGX LLC; STRATATECH CORPORATION; SUCAMPO PHARMA AMERICAS LLC; VTESSE LLC (F/K/A VTESSE INC.); MALLINCKRODT PHARMACEUTICALS IRELAND LIMITED; MALLINCKRODT PHARMA IP TRADING UNLIMITED COMPANY (F/K/A MALLINCKRODT PHARMA IP TRADING D.A.C.); INFACARE PHARMACEUTICAL CORPORATION; ST SHARED SERVICES LLC; IKARIA THERAPEUTICS LLC; INO THERAPEUTICS LLC
Reel/Frame 065609/0322 →
RELEASE OF SECURITY INTEREST Recorded Jan 31, 2017
From: DEUTSCHE BANK AG NEW YORK BRANCH
To: MALLINCKRODT NUCLEAR MEDICINE LLC
Reel/Frame 041131/0213 →
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Jul 13, 2016
From: MALLINCKRODT LLC
To: MALLINCKRODT NUCLEAR MEDICINE LLC
Reel/Frame 039149/0234 →
SECURITY INTEREST Recorded Mar 19, 2014
From: MALLINCKRODT INTERNATIONAL FINANCE S.A.; MALLINCKRODT CB LLC; MALLINCKRODT FINANCE GMBH; MALLINCKRODT US HOLDINGS INC.; MALLINCKRODT CARIBBEAN, INC.; MALLINCKRODT US POOL LLC; MALLINCKRODT INC.; LUDLOW CORPORATION; CNS THERAPEUTICS, INC.; ENTERPRISES HOLDINGS, INC.; MALLINCKRODT ENTERPRISES LLC; MALLINCKRODT LLC; LAFAYETTE PHARMACEUTICALS LLC; LIEBEL-FLARSHEIM COMPANY LLC; MALLINCKRODT BRAND PHARMACEUTICALS, INC; MALLINCKRODT VETERINARY, INC.; MALLINCKRODT US HOLDINGS LLC; IMC EXPLORATION COMPANY; MEH, INC; MALLINCKRODT ENTERPRISES HOLDINGS, INC.
To: DEUTSCHE BANK AG NEW YORK BRANCH
Reel/Frame 032480/0001 →
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Jul 9, 2013
From: BARBOSA, LUIS A.M.M.
To: MALLINCKRODT INC.
Reel/Frame 030755/0690 →
CHANGE OF LEGAL ENTITY Recorded Jul 9, 2013
From: MALLINCKRODT INC.
To: MALLINCKRODT LLC
Reel/Frame 030772/0430 →